Molecular cross-talk between members of distinct families of selenium containing proteins

Molecular Nutrition and Food Research

Volumn 58, Issue 1, 2014, Pages 117-123

  Ansong, Emmanuel ^a   Yang, Wancai ^a,b   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Clinical outcome; Glutathione peroxidase; Selenium binding protein 1

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; SELENBP1 PROTEIN, HUMAN; SELENIUM; SELENIUM BINDING PROTEIN; SELENOPROTEIN;

CLINICAL OUTCOME; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW; SELENIUM-BINDING PROTEIN 1;

CANCER; CLINICAL OUTCOME; GLUTATHIONE PEROXIDASE; SELENIUM-BINDING PROTEIN 1;

GLUTATHIONE PEROXIDASE; HUMANS; NEOPLASMS; SELENIUM; SELENIUM-BINDING PROTEINS; SELENOPROTEINS;

EID: 84891464515     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300543     Document Type: Review

References (51)

1. Lobanov, A.V., Hatfield, D.L., Gladyshev, V.N., Eukaryotic selenoproteins and selenoproteomes. Biochim. Biophys. Acta. 2009, 1790, 1424-1428.
2. Berry, M.J., Banu, L., Chen, Y., Mandel, S.J. et al., Recognition of UGA as a selenocysteine codon in Type I deiodinase requires sequences in the 3' untranslated region. Nature 1991, 353, 273-276.
3. Bellinger, F.P., Raman, A.V., Reeves, M.A., Berry, M.J., Regulation and function of selenoproteins in human disease. Biochem. J. 2009, 422, 11-22.
4. Driscoll, D.M., Copeland, P.R., Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 2003, 23, 17-40.
5. Kryukov, G.V., Castellano, S., Novoselov, S.V., Lobanov, A.V. et al., Characterization of mammalian selenoproteomes. Science 2003, 300, 1439-1443.
6. Rayman, M.P., Selenium and human health. Lancet 2012, 379, 1256-1268.
7. Davis, C.D., Tsuji, P.A., Milner, J.A., Selenoproteins and Cancer Prevention. Annu. Rev. Nutr. 2012, 32, 73-95.
8. Bansal, M.P., Oborn, C.J., Danielson, K.G., Medina, D., Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis 1989, 10, 541-546.
9. Chang, P.W., Tsui, S.K., Liew, C., Lee, C.C. et al., Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell. Biochem. 1997, 64, 217-224.
10. Chen, G., Wang, H., Miller, C.T., Thomas, D.G. et al., Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol. 2004, 202, 321-329.
11. Raucci, R., Colonna, G., Guerriero, E., Capone, F. et al., Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim. Biophys. Acta. 2011, 1814, 513-522.
12. Huang, C., Ding, G., Gu, C., Zhou, J. et al., Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1alpha to Promote Hepatocellular Carcinoma Invasiveness. Clin. Cancer Res. 2112, 18, 3042-3053.
13. Porat, A., Sagiv, Y., Elazar, Z., A 56-kDa selenium-binding protein participates in intra-Golgi protein transport. J. Biol. Chem. 2000, 275, 14457-14465.
14. Jeong, J.Y., Wang, Y., Sytkowski, A.J., Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem. Biophys. Res. Commun. 2009, 379, 583-588.
15. Yang, M., Sytkowski, A.J., Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. Cancer Res. 1998, 58, 3150-3153.
16. He, Q.Y., Cheung, Y.H., Leung, S.Y., Yuen, S.T. et al., Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 2004, 4, 3276-3287.
17. Wu, C., Luo, Z., Chen, X., Wu, C. et al., Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. Oncol. Rep. 2009, 21, 1429-1437.
18. Zhang, J., Zhan, N., Dong, W.G., Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions. Med. Oncol. 2011, 28, 951-957.
19. Silvers, A.L., Lin, L., Bass, A.J., Chen, G. et al., Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin. Cancer Res. 2013, 16, 2009-2021.
20. Zhang, P., Zhang, C., Wang, X., Liu, F. et al., The expression of selenium-binding protein 1 is decreased in uterine leiomyoma. Diagn. Pathol. 2010, 5, 80.
21. Kim, H., Kang, H.J., You, K.T., Kim, S.H. et al., Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 2006, 6, 3466-3476.
22. Li, T., Yang, W., Li, M., Byun, D.S. et al., Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol. Nutr. Food Res. 2008, 52, 1289-1299.
23. Corona, G., De Lorenzo, E., Elia, C., Simula, M.P. et al., Differential proteomic analysis of hepatocellular carcinoma. Int. J. Oncol. 2010, 36, 93-99.
24. McClain, C.M., Friedman, D.B., Hajri, T., Coffin, C.M., Cates, J.M., Predicting dedifferentiation in liposarcoma: a proteomic approach. Virchows Arch. 2013, 463, 85-92.
25. Huang, K.C., Park, D.C., Ng, S.K., Lee, J.Y. et al., Selenium binding protein 1 in ovarian cancer. Int. J. Cancer 2006, 118, 2433-2440.
26. Zhang, C., Wang, Y.E., Zhang, P., Liu, F. et al., Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum. Pathol. 2010, 41, 255-261.
27. Stammer, K., Edassery, S.L., Barua, A., Bitterman, P. et al., Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol. Oncol. 2008, 109, 115-121.
28. Pohl, N.M., Tong, C., Fang, W., Bi, X. et al., Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS. One 2009, 4, e7774.
29. Pass, H.I., Liu, Z., Wali, A., Bueno, R. et al., Gene expression profiles predict survival and progression of pleural mesothelioma. Clin. Cancer Res. 2004, 10, 849-859.
30. Zhang, J., Dong, W.G., Lin, J., Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma. Med. Oncol. 2011, 28, 481-487.
31. Zhang, S., Li, F., Younes, M., Liu, H. et al., Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS. One 2013, 8, e63702.
32. Lubos, E., Loscalzo, J., Handy, D.E., Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal 2011, 15, 1957-1997.
33. Baliga, M.S., Diwadkar-Navsariwala, V., Koh, T., Fayad, R. et al., Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol. Nutr. Food Res. 2008, 52, 1300-1304.
34. Baliga, M.S., Wang, H., Zhuo, P., Schwartz, J.L., Diamond, A.M., Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol. Trace Elem. Res. 2007, 115, 227-242.
35. Zhuo, P., Diamond, A.M., Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim. Biophys. Acta. 2009, 115, 227-242.
36. Hu, Y.J., Diamond, A.M., Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res. 2003, 63, 3347-3351.
37. Zhuo, P., Goldberg, M., Herman, L., Lee, B.S. et al., Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res. 2009, 69, 8183-8190.
38. Lei, C., Niu, X., Wei, J., Zhu, J., Zhu, Y., Interaction of glutathione peroxidase-1 and selenium in endemic dilated cardiomyopathy. Clin. Chim. Acta. 2009, 399, 102-108.
39. Winter, J.P., Gong, Y., Grant, P.J., Wild, C.P., Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Coron. Artery Dis. 2003, 14, 149-153.
40. Tang, N.P., Wang, L.S., Yang, L., Gu, H.J. et al., Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clin. Chim. Acta. 2008, 395, 89-93.
41. Kato, K., Oguri, M., Kato, N., Hibino, T. et al., Assessment of genetic risk factors for thoracic aortic aneurysm in hypertensive patients. Am. J. Hypertens. 2008, 21, 1023-1027.
42. Ming, X., Johnson, W.G., Stenroos, E.S., Mars, A. et al., Genetic variant of glutathione peroxidase 1 in autism. Brain Dev. 2010, 32, 105-109.
43. Pera, J., Slowik, A., Dziedzic, T., Pulyk, R. et al., Glutathione peroxidase 1 C593T polymorphism is associated with lobar intracerebral hemorrhage. Cerebrovasc. Dis. 2008, 25, 445-449.
44. Solodilova, M.A., Ivanov, V.P., Polonikov, A.V., Khoroshaia, I.V. et al., [Heterozygosity of 198LEU mutant allele in glutathione peroxidase-1 gene as a risk factor of bronchial asthma associated with smoking]. Ter. Arkh. 2007, 79, 33-36.
45. Kuzuya, M., Ando, F., Iguchi, A., Shimokata, H., Glutathione peroxidase 1 Pro198Leu variant contributes to the metabolic syndrome in men in a large Japanese cohort. Am. J. Clin. Nutr. 2008, 87, 1939-1944.
46. Fang, W., Goldberg, M.L., Pohl, N.M., Bi, X. et al., Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis 2010, 31, 1360-1366.
47. Jerome-Morais, A., Wright, M.E., Liu, R., Yang, W. et al., Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate 2012, 72, 1006-1012.
48. Huang, C., Ding, G., Gu, C., Zhou, J. et al., Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1alpha to Promote Hepatocellular Carcinoma Invasiveness. Clin. Cancer Res. 2012, 18, 3042-3053.
49. Scortegagna, M., Martin, R.J., Kladney, R.D., Neumann, R.G., Arbeit, J.M., Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 2009, 69, 2638-2646.
50. Pouyssegur, J., Mechta-Grigoriou, F., Redox regulation of the hypoxia-inducible factor. Biol. Chem. 2006. 387, 1337-1346.
51. Zhang, C., Xu, W., Pan, W., Wang, N. et al., Selenium-binding protein 1 may decrease gastric cellular proliferation and migration. Int. J. Oncol. 2013, 42, 1620-1629.